CARsgen Therapeutics and CrownBio complete CAR-T study for gastric cancer
Research in its very early stages uses engineered immune cells (CAR-T) to target gastric cancer tumors.
Read SourceResearch in its very early stages uses engineered immune cells (CAR-T) to target gastric cancer tumors.
Read SourceFor press inquiries about the Gastric Cancer Foundation, please contact: Mediainfo@gastriccancer.org
Together, we will defeat stomach cancer.
Together, we will defeat stomach cancer.
MORE INFODONATE